Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · Real-Time Price · USD
1.830
-0.090 (-4.69%)
Sep 15, 2025, 12:19 PM EDT - Market open
Shattuck Labs Revenue
Shattuck Labs had revenue of $3.00M in the twelve months ending June 30, 2025, down -27.33% year-over-year. In the year 2024, Shattuck Labs had annual revenue of $5.72M with 245.26% growth.
Revenue (ttm)
$3.00M
Revenue Growth
-27.33%
P/S Ratio
32.62
Revenue / Employee
$68,114
Employees
44
Market Cap
87.66M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 5.72M | 4.06M | 245.26% |
Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
STTK News
- 20 days ago - Shattuck Labs Announces Closing of up to $103 Million Private Placement and Appointments to Board of Directors - GlobeNewsWire
- 25 days ago - Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease - GlobeNewsWire
- 4 weeks ago - Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Shattuck Labs Announces Oversubscribed Private Placement of Up to Approximately $103 Million - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Participation in Upcoming Leerink Partners Therapeutics Forum: I&I and Metabolism - GlobeNewsWire
- 4 months ago - Shattuck Labs Reports First Quarter 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 months ago - Shattuck Labs Announces Participation in Upcoming 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 6 months ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Business Highlights - GlobeNewsWire